Free Trial

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Polar Capital Holdings Plc

Acadia Healthcare logo with Medical background

Polar Capital Holdings Plc reduced its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 9.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 349,761 shares of the company's stock after selling 34,818 shares during the quarter. Polar Capital Holdings Plc owned about 0.38% of Acadia Healthcare worth $13,868,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Lindbrook Capital LLC lifted its holdings in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock valued at $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of Acadia Healthcare by 69.4% during the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after buying an additional 345 shares during the period. Nisa Investment Advisors LLC boosted its position in Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after acquiring an additional 301 shares during the last quarter. Signaturefd LLC grew its stake in Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after acquiring an additional 1,004 shares during the period. Finally, Fifth Third Bancorp raised its holdings in Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock valued at $50,000 after acquiring an additional 454 shares during the last quarter.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. KeyCorp cut their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Barclays reduced their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 14th. Mizuho decreased their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. Bank of America cut their price objective on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Finally, Guggenheim started coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price for the company. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.

Read Our Latest Analysis on ACHC

Acadia Healthcare Stock Down 4.1%

Shares of Acadia Healthcare stock traded down $1.07 during trading hours on Monday, hitting $25.08. 1,873,033 shares of the company's stock traded hands, compared to its average volume of 1,708,288. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41. The stock has a 50 day simple moving average of $26.19 and a 200-day simple moving average of $35.49. The company has a market cap of $2.31 billion, a PE ratio of 8.22, a PEG ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.05. The company had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare's revenue for the quarter was up .3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.84 EPS. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Profile

(Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines